BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 24
• 26
• 27
• 28
• 29
• 30

• Business

  BioDelivery Sciences Reports Third Quarter 2017 Financial Results and Provides Corporate Update

  Net revenue for the third quarter ended September 30, 2017, was approximately $11.3 million, compared to $8.7 million in the second quarter of 2017, an increase of 29%, and $3.6 million in the third quarter of 2016.

  November 9, 2017

   · 

  28 min read
• Business

  Varex Imaging Announces Financial Results for Fourth Quarter and Fiscal Year 2017

  Revenues increased 13% to $698M, including $61M from the acquired imaging business

  November 9, 2017

   · 

  30 min read
• Biotech Beach

  Neurocrine’s INGREZZA, First FDA Approved Product for the Treatment of Tardive Dyskinesia, Receives Outstanding Therapeutic Product Award from Prestigious California Life Sciences Association

  CLSA will honor this year’s winners at the 2017 Pantheon DiNA Awards ceremony on Friday, November 10, at the Marriott Marquis in San Francisco.

  November 9, 2017

   · 

  6 min read
• Business

  Aytu BioScience Provides Fiscal First Quarter 2018 Business Update - Live Conference Call and Webcast Today at 4:30 pm ET

  The Company will host a live conference call and webcast today at 4:30 p.m. ET. Conference call details are provided at the end of this press release.

  November 9, 2017

   · 

  19 min read
• Business

  Endo Reports Third-Quarter 2017 Financial Results

  Revenues of $787M, an 11 percent decrease compared to third-quarter 2016 revenues of $884M.

  November 9, 2017

   · 

  107 min read
• Business

  Sangamo Reports Third Quarter 2017 Financial Results

  Sangamo today reported its third quarter 2017 financial results and recent accomplishments.

  November 9, 2017

   · 

  12 min read
• Business

  Sangamo Announces Strategic Investment in Manufacturing and Appointment of Andy Ramelmeier as Head of Technical Operations

  Sangamo’s strategic investment in large scale manufacturing capacity and capabilities represents a balanced approach to meet the needs of its rapidly expanding pipeline of genomic therapy product candidates.

  November 9, 2017

   · 

  4 min read
• Business

  AcelRx Pharma Reports Third Quarter 2017 Financial Results

  AcelRx Pharma today reported third quarter 2017 financial results.

  November 9, 2017

   · 

  12 min read
• Business

  VolitionRx Announces Third Quarter 2017 Financial Results and Business Update

  Volition management will host a conference call tomorrow, November 10, at 8:30 a.m. U.S. Eastern Time to discuss these results. Conference call details may be found below.

  November 9, 2017

   · 

  9 min read
• Business

  Sophiris Bio Reports Third Quarter Financial Results and Key Corporate Highlights

  The Company reported a net loss of $2.7M for the three months ended September 30, 2017 compared to a net loss of $4.3M for the three months ended September 30, 2016.

  November 9, 2017

   · 

  15 min read